US38000Q1022 - GLYC - A1W8HZ (XNMS)
GLYCOMIMETICS INC Aktie
0,17 USD
Aktuelle Kurse von GLYCOMIMETICS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
GLYC
|
USD
|
20.09.2024 01:29
|
0,17 USD
| 0,17 USD | 2,18 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -2,15 % | -5,23 % | -30,33 % | -94,25 % | -88,29 % | -96,28 % |
Firmenprofil zu GLYCOMIMETICS INC Aktie
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.
Unternehmensdaten zur GLYCOMIMETICS INC Aktie
Name GLYCOMIMETICS INC
Firma GlycoMimetics, Inc.
Symbol GLYC
Website https://www.glycomimetics.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A1W8HZ
ISIN US38000Q1022
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Harout Semerjian
Marktkapitalisierung 10 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 9708 Medical Center Drive, 20850 Rockville
IPO Datum 2014-01-10
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | GKO.F |
NASDAQ | GLYC |
Weitere Aktien
Investoren die GLYCOMIMETICS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024